Impact of pulmonary hypertension on arteriovenous fistula failure of hemodialysis patients: A 10 years follow-up cohort study.

Li SongZi-Lin QuanLi-Yan ZhaoDong-Mei CuiMi ZhongLi-Fang ZhouChun-Yan SunYing-Gui ChenYa-Wen MoZhonglin FengYiming TaoZhiming YeYuanhan ChenHuaban LiangTing LinShuangxin LiuXin-Ling LiangXia Fu

Published in: The journal of vascular access (2021)

The secondary pulmonary hypertension after AVF creation did not increase the risk of AVF failure in MHD patients, but significantly increased the risk of mortality for this portion of the patients. Future larger sample sizes, multi-center, and prospective trials are needed to make sure which type of access will benefit on their survival for MHD patients with SPAP ⩾35 mmHg.

Keyphrases

peritoneal dialysis
end stage renal disease
pulmonary hypertension
chronic kidney disease
type diabetes
cardiovascular disease
risk factors
pulmonary artery
newly diagnosed
cardiovascular events
ejection fraction
patient reported outcomes